Guillaume Mabilleau, Béatrice Bouvard. Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models. Peptides, 2024, 177, pp.9. ⟨10.1016/j.peptides.2024.171228⟩. ⟨hal-04591081⟩
Accès au texte intégral et bibtex
ref_biblio
Valentin Gilet, Guillaume Mabilleau, Matthieu Loumaigne, Laureen Coic, Raffaele Vitale, et al.. Superpixels meet essential spectra for fast Raman hyperspectral microimaging. Optics Express, 2024, 32 (1), pp.932-948. ⟨10.1364/OE.509736⟩. ⟨hal-04409250⟩
Accès au texte intégral et bibtex
ref_biblio
Najia Jeroundi, Charlotte Roy, Laetitia Basset, Pascale Pignon, Laurence Preisser, et al.. Glycogenesis and glyconeogenesis from glutamine, lactate and glycerol support human macrophage functions. EMBO Reports, In press, ⟨10.1038/s44319-024-00278-4⟩. ⟨hal-04745249⟩
Accès au texte intégral et bibtex
ref_biblio
Julia Herrou, Guillaume Mabilleau, Jean-Michel Lecerf, Thierry Thomas, Emmanuel Biver, et al.. Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity. Calcified Tissue International, 2023, 114 (2), pp.86-97. ⟨10.1007/s00223-023-01150-8⟩. ⟨hal-04446475⟩
Accès au bibtex
ref_biblio
François Robin, Daniel Chappard, Patricia Leroyer, Chloe Latour, Guillaume Mabilleau, et al.. Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis. FASEB Journal, 2023, 37 (11), pp.e23245. ⟨10.1096/fj.202301184R⟩. ⟨hal-04279236⟩
Accès au bibtex
ref_biblio
Aleksandra Mieczkowska, Guillaume Mabilleau. Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen. Calcified Tissue International, 2023, ⟨10.1007/s00223-023-01105-z⟩. ⟨hal-04139601⟩
Accès au texte intégral et bibtex
ref_biblio
Antoine Chretien, Guillaume Mabilleau, Jean Lebacq, Pierre-Louis Docquier, Catherine Behets. Beneficial Effects of Zoledronic Acid on Tendons of the Osteogenesis Imperfecta Mouse (Oim). Pharmaceuticals, 2023, 16 (6), pp.832. ⟨10.3390/ph16060832⟩. ⟨hal-04139612⟩
Accès au texte intégral et bibtex
ref_biblio
Stéphanie Fabre, Morgane Bourmaud, Guillaume Mabilleau, Ruben Goulet, Aude Couturier, et al.. Lrp5 p. Val667Met Variant Compromises Bone Mineral Density and Matrix Properties in Osteoporosis. JBMR Plus, 2023, 7 (6), ⟨10.1002/jbm4.10741⟩. ⟨hal-04139607⟩
Accès au texte intégral et bibtex
ref_biblio
Benoit Gobron, Malory Couchot, Nigel Irwin, Erick Legrand, Béatrice Bouvard, et al.. Development of a First‐in‐Class Unimolecular Dual GIP / GLP ‐2 Analogue, GL ‐0001, for the Treatment of Bone Fragility. Journal of Bone and Mineral Research, 2023, 38 (5), pp.733-748. ⟨10.1002/jbmr.4792⟩. ⟨hal-04139591⟩
Accès au texte intégral et bibtex
ref_biblio
Benoit Gobron, Malory Couchot, Nigel Irwin, Erick Legrand, Béatrice Bouvard, et al.. Development of a first-in-class unimolecular dual GIP/GLP-2 analogue, GL-0001, for the treatment of bone fragility. 2022. ⟨hal-03766741⟩
